Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia

NCT00789672 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Amblyopia

Interventions

DRUG: levodopa/carbidopa
DEVICE: patching
DRUG: levodopa/carbidopa

Sponsor

Jaeb Center for Health Research

Collaborators

[object Object]